H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares traded.
H. Lundbeck A/S Trading Down 0.0%
The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.71 and a current ratio of 1.15. The firm has a market cap of $21.91 billion, a PE ratio of 25.00 and a beta of 0.68. The stock has a 50-day simple moving average of $22.00 and a two-hundred day simple moving average of $22.00.
About H. Lundbeck A/S
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Recommended Stories
- Five stocks we like better than H. Lundbeck A/S
- What is the Australian Securities Exchange (ASX)
- Five Below Pops on Strong Earnings, But Rally May Stall
- 10 Best Airline Stocks to Buy
- Intel’s Dual Gamble: AI Innovation Now, Foundry Fortunes Later?
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- X: 1 Reason to Bet on U.S. Steel, and 1 Reason to Hold Back
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
